Stocks and Investing Stocks and Investing
Mon, October 5, 2020

Geoff Meacham Initiated (VIR) at Strong Buy and Held Target at $55 on, Oct 5th, 2020


Published on 2024-10-27 14:00:54 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Initiated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $55 on, Oct 5th, 2020.

Geoff has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Decreased Target to $29 on, Friday, September 11th, 2020


These are the ratings of the 3 analyists that currently disagree with Geoff


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $80 on, Monday, September 21st, 2020
  • Paul Choi of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $54 on, Monday, September 14th, 2020
  • Alan Carr of "Needham" Initiated at Strong Buy and Held Target at $62 on, Thursday, August 20th, 2020
Contributing Sources